Other Major Cardiovascular Procedures DRG Reimbursement

DRG 272 encompasses major cardiovascular procedures without Complication or Comorbidity or Major Complication or Comorbidity, focusing on non-coronary cardiac and major vascular operations. Proper assignment to this Diagnosis-Related Group is important for inpatient reimbursement because the presence or absence of Complication or Comorbidity or Major Complication or Comorbidity shifts payment tiers under Medicare.

DRG 272 Overview

DRG 272 covers admissions for major cardiovascular procedures other than coronary bypass that do not have a Complication or Comorbidity or a Major Complication or Comorbidity recorded. It typically includes procedures such as valve repairs or replacements and major vascular operations when no qualifying secondary diagnoses increase complexity. This Diagnosis-Related Group matters for Medicare payment because the absence of Complication or Comorbidity or Major Complication or Comorbidity places cases in a lower payment tier, affecting inpatient reimbursement rates. Accurate coding of procedures and secondary diagnoses determines grouping into this Diagnosis-Related Group and the associated Medicare inpatient payment.

Acute perioperative randomized or pragmatic trials comparing different operative or immediate post-operative management strategies for non-coronary major cardiovascular surgeries (for example, valve-sparing procedures, complex aortic repairs, or combined valve and arrhythmia procedures). These studies enroll adult inpatients undergoing major cardiovascular operations captured by DRG 272 to evaluate short-term endpoints such as intraoperative blood loss, hemodynamic stability, ICU length of stay, transfusion requirements, and 30-day complication rates. Results inform surgeons and hospital administrators about approaches that reduce perioperative morbidity and resource use, which directly impacts case costs and inpatient reimbursement profiles.
Comparative effectiveness and quality-improvement studies assessing different intraoperative technologies, monitoring protocols, or enhanced recovery pathways for patients receiving complex cardiovascular procedures without significant comorbid complications. These observational cohort or cluster-randomized studies focus on heterogeneous surgical populations in tertiary centers comparing strategies such as advanced hemodynamic monitoring, blood conservation bundles, or protocolized anticoagulation management to standard care, with outcomes including complication incidence, readmission, and hospital length of stay. Payors and providers use evidence from these studies to refine clinical pathways that target high-cost drivers in DRG 272 cases and to support value-based payment models.
Post-discharge outcomes and utilization research examining 30- to 365-day functional recovery, rehospitalization, and outpatient resource use among survivors of major cardiovascular procedures without CC/MCC. These longitudinal cohort studies study diverse patients discharged after index admission, measuring rehabilitation needs, medication adherence, arrhythmia or heart failure progression, and costs of post-acute care across settings to identify predictors of readmission and long-term resource use. Findings guide discharge planning, bundled-payment risk stratification, and payer decisions about coverage for post-acute services that can reduce avoidable downstream spending associated with this DRG.

Acute perioperative randomized or pragmatic trials comparing different operative or immediate post-operative management strategies for non-coronary major cardiovascular surgeries (for example, valve-sparing procedures, complex aortic repairs, or combined valve and arrhythmia procedures). These studies enroll adult inpatients undergoing major cardiovascular operations captured by DRG 272 to evaluate short-term endpoints such as intraoperative blood loss, hemodynamic stability, ICU length of stay, transfusion requirements, and 30-day complication rates. Results inform surgeons and hospital administrators about approaches that reduce perioperative morbidity and resource use, which directly impacts case costs and inpatient reimbursement profiles.
Comparative effectiveness and quality-improvement studies assessing different intraoperative technologies, monitoring protocols, or enhanced recovery pathways for patients receiving complex cardiovascular procedures without significant comorbid complications. These observational cohort or cluster-randomized studies focus on heterogeneous surgical populations in tertiary centers comparing strategies such as advanced hemodynamic monitoring, blood conservation bundles, or protocolized anticoagulation management to standard care, with outcomes including complication incidence, readmission, and hospital length of stay. Payors and providers use evidence from these studies to refine clinical pathways that target high-cost drivers in DRG 272 cases and to support value-based payment models.
Post-discharge outcomes and utilization research examining 30- to 365-day functional recovery, rehospitalization, and outpatient resource use among survivors of major cardiovascular procedures without CC/MCC. These longitudinal cohort studies study diverse patients discharged after index admission, measuring rehabilitation needs, medication adherence, arrhythmia or heart failure progression, and costs of post-acute care across settings to identify predictors of readmission and long-term resource use. Findings guide discharge planning, bundled-payment risk stratification, and payer decisions about coverage for post-acute services that can reduce avoidable downstream spending associated with this DRG.

OpenPayer

Summary & Overview

Other Major Cardiovascular Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 272 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes